Facebook Twitter RSS Feed

You are here

By: Kathy F. Mahdoubi

The past year has been a groundbreaking one for neurology. Not only have at least three new biomarkers been identified for Alzheimer’s disease, but various molecular imaging agents used to visualize neurodegenerative disorders are now either available or being conveyed toward regulatory approval for clinical use. Parkinson’s research, too, has progressed at an astonishing rate with the spoils being a new method of detection and a therapeutic technique that could potentially leave patients tremor-free for life. Several psychiatric disorders are being seen first-hand by targeting the dopaminergic system of the brain. Neuroendocrine tumor (NET) imaging also is pushing forward with a preliminary nod from the FDA in the form of an orphan drug application for NET management.


 - Robert W. Atcher, PhD, MBA
By: Robert W. Atcher, PhD, MBA
When I began my PhD research almost 40 years ago, nuclear medicine research was almost entirely focused on diagnosis. 
 - Irving L. Weissman, MD
By: Kathy F. Mahdoubi
Irving L. Weissman, MD’s stem cell research using PET and optical imaging has revealed how a novel antibody-based biomarker highlights areas of residual cancer with broad potential for therapeutic...
 - RBC Tube
By: Kathy F. Mahdoubi
An exploration of recent projects at Argonne National Laboratory and Johns Hopkins University traverse the numerical and graphical landscape of cerebral blood flow, the pathology of malaria, brain...
 - Scanner Tech
By: Anna Steere
As imaging studios have markedly increased in the past two decades, so has the concern among some clinicians and media surrounding radiation dose management.
 - Brain Roadmap
By: Lisa Fratt
“Alzheimer’s disease is probably the most underfunded disease in the U.S.,” charges Dean M. Hartley, PhD, director of science initiatives, medical and scientific relations, for the Alzheimer’s...
 - Aortic aneurysm
By: Kathy F. Mahdoubi
Inflammation plays a major role in disease processes.
 - AT1R Uptake
By: Candace Stuart
Molecular imaging is beginning to give cardiologists insight into biological processes behind heart failure, knowledge that may allow them to monitor disease progression and tailor therapies. But...
 - Quantitative Imaging Network
By: Evan Godt
The art of image interpretation is giving way to objective scientific quantification.